Byers
Benjamin A. Byers, North Easton, MA US
Patent application number | Description | Published |
---|---|---|
20150150983 | Intra-articular Formulations and Methods for Treatment of Osteoarthritis - Intra-articular formulations and methods are provided for treating joint conditions, such as osteoarthritis. The formulations include an effective amount of recombinant human growth differentiation factor-5 (rhGDF-5) and an acidic vehicle, where the formulation is an intra-articular injection formulation. The formulations described herein can be used for treating joint conditions (e.g., osteoarthritis) via intra-articular injection in a subject in need thereof. | 06-04-2015 |
20150190469 | Methods for Forming Compositions for Treating Joints Comprising Bone Morphogenetic Protein and Hyaluronic Acid - Methods and compositions are disclosed for an intra-articular injection for the treatment of osteoarthritis. The methods and compositions comprising combinations of hyaluronic acid and a bone morphogenetic protein, like rhGDF-5, can be useful for any synovial joint, including the knee, shoulder, hip, ankle, hands, spinal facet, or temporomandibular joint, both for the relief of pain and for slowing disease progression. | 07-09-2015 |
Brady L. Byers, Tillamook, OR US
Patent application number | Description | Published |
---|---|---|
20130186733 | Double-Sealed, Bearingless, Reciprocating Conveyor With Slat-Supporting Guide Trough Subdecks - A reciprocating slat conveyor includes a plurality of laterally and substantially parallel longitudinal trough-like subdecks and a plurality of longitudinal slats adjacent to and parallel to each other. The slats are in a sliding relationship with a pair of adjacent subdecks and cover the longitudinal space between the pair of adjacent subdecks. The subdecks longitudinally support two adjacent slats at or near a slat longitudinal side edge. The subdecks conduct the movement of the slats, preferably without distinct bearing elements therebetween. Some preferred embodiments include raised double-seal system. | 07-25-2013 |
20140090960 | Bearingless Reciprocating Slat-Type Conveyor Assemblies - A tipper retrofit bearingless reciprocating slat-type conveyor assembly | 04-03-2014 |
Brent W. Byers, Plano, TX US
Patent application number | Description | Published |
---|---|---|
20130105656 | HOLDER MECHANISM FOR A MULTI-FUNCTION ELECTRONIC DEVICE | 05-02-2013 |
Bryce Byers, Orem, UT US
Patent application number | Description | Published |
---|---|---|
20130304621 | Algorithmic Trading Management System and Method - Embodiments of the invention are directed to a computer-implemented system and method for facilitating electronic market participation of traders. The algorithmic trading management system may comprise an algorithm and/or sequence usage and construction module providing conditional user interface features for allowing traders to construct algorithms or sequences to structure trading orders. The system may additionally include sequence modification components for allowing traders to modify algorithms collected from external sources in order to customize trading orders. The system may further include operator intervention tools for allowing traders to manually influence sequence execution through a user interface. | 11-14-2013 |
Charles Calvin Byers, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20150156568 | MULTI-BEAM FREE SPACE OPTICAL ENDPOINT - Free space optics (FSO) is a wireless technology that utilizes optical frequencies. Previously available FSO transceivers are restricted to point-to-point links because of the high directivity of laser light used to transmit data. By contrast, various implementations disclosed herein include a multi-beam FSO apparatus that is less reliant on point-to-point links, and includes a lens assembly and a planar array of optical communication devices. The lens assembly includes at least one surface shaped to direct ingress light received substantially within a first angular range towards a focal plane, and to direct egress light away from the focal plane into the first angular range. The planar array includes a plurality of optical communication devices arranged in association with the focal plane of the lens assembly, wherein each of the plurality of optical communication devices characterizes at least one of a plurality of optical communication link endpoints. | 06-04-2015 |
20150349881 | CONTROL SYSTEM FOR MULTI-BEAM FREE SPACE OPTICAL ENDPOINT - Free space optics (FSO) is a wireless technology that utilizes optical frequencies. Previously available FSO transceivers are restricted to point-to-point links because of the high directivity of laser light used to transmit data. By contrast, various implementations disclosed herein include a multi-beam FSO apparatus that is less reliant on point-to-point links, and includes a lens assembly and a planar array of optical communication devices. The lens assembly includes at least one surface shaped to direct ingress light received substantially within a first angular range towards a focal plane, and to direct egress light away from the focal plane into the first angular range. The planar array includes a plurality of optical communication devices arranged in association with the focal plane of the lens assembly, wherein each of the plurality of optical communication devices characterizes at least one of a plurality of optical communication link endpoints. | 12-03-2015 |
Cindy Byers, Mesa, AZ US
Patent application number | Description | Published |
---|---|---|
20150082805 | AIR TURBINE STARTER INCLUDING A LIGHTWEIGHT, LOW DIFFERENTIAL PRESSURE CHECK VALVE - An air turbine starter includes a starter housing and a check valve. The check valve is disposed within the starter housing and is configured, in response to a pressure differential across the check valve, to selectively allow and prevent lubricant to flow therefrom. The check valve includes a valve includes a valve body, a valve seat, a valve bore, a valve element, and a plurality of rounded grooves. The valve bore is formed in the valve body between the valve seat and the lubricant outlet port. The valve element is disposed within the valve bore and is movable between a plurality of open positions and a closed position. The rounded grooves are formed in the valve body, and are disposed adjacent to, and in fluid communication with, the valve bore to improve lubricant to flow past the valve element when the valve element is in an open position. | 03-26-2015 |
Crystal Byers, Allston, MA US
Patent application number | Description | Published |
---|---|---|
20140303232 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS - This invention provides for a compound of formula (I): | 10-09-2014 |
Crystal Byers, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20160106842 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS - This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R | 04-21-2016 |
Crystal Byers US
Patent application number | Description | Published |
---|---|---|
20160106842 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS - This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R | 04-21-2016 |
David Byers, Halifax CA
Patent application number | Description | Published |
---|---|---|
20100076028 | Design and Synthesis of Novel Antimicrobials - The synthesis and activity of novel LpxA inhibitors is described, these inhibitors present antibacterial activity. The compounds were designed based on a receptor model developed using the crystal structure of LpxA and are arranged to have a favorable binding interaction at the active site of the enzyme. In particular, the compounds present the following formula (I) where V, W, X, Y and Z can be independently C, S, N or O and P1, P2 and P3 are ligands to bind to the three points of the proposed pharmacophore model. They can be chosen from a variety of groups. | 03-25-2010 |
David M. Byers, Halifax CA
Patent application number | Description | Published |
---|---|---|
20100137388 | Therapeutic Pro-Antibiotic Agents and Methods of Use Thereof - The present invention provides for therapies characterized in part by co-administration or combination of antibiotic agents with medicinal compositions comprising as the pro-antibiotic active ingredient either a compound represented by a formula [I] or a pharmaceutically acceptable composite thereof; [wherein X represents oxygen, sulfur, NH, or N-alkyl; R | 06-03-2010 |
Gary Allen Byers, Sandia Park, NM US
Patent application number | Description | Published |
---|---|---|
20140261824 | Slurry Supply and/or Chemical Blend Supply Apparatuses, Processes, Methods of Use and Methods of Manufacture - A slurry and/or chemical blend supply apparatus suitable for providing slurry and/or chemical blend to chemical mechanical planarization (CMP) tools or other tools in a semiconductor fabrication facility, related processes, methods of use and methods of manufacture. The slurry and/or chemical blend supply apparatus includes one or more of the following: feed module, blend module, analytical module and distribution module. | 09-18-2014 |
Helen Byers, Surrey GB
Patent application number | Description | Published |
---|---|---|
20090275495 | METHODS AND COMPOSITIONS RELATING TO ALZHEIMER'S DISEASE - Methods and compositions relating to Alzheimer's disease are provided, including proteins that are differentially expressed in Alzheimer's disease as compared to the normal state. Further provided are methods, particularly experimental paradigms, for the identification of differential expressed proteins that are potential molecular targets for compounds to treat or prevent Alzheimer's disease. Also provided are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimer's disease. | 11-05-2009 |
20110111513 | MASS SPECTROMETRIC ANALYSIS - The disclosure provides a method for assaying for a target analyte, comprising providing a plurality of samples which may comprise the target analyte, wherein each sample is differentially labelled with a mass label or a combination of mass labels, wherein the mass labels are from a set of mass labels, wherein each mass label is an isobaric mass label comprising a mass spectrometrically distinct mass marker group, such that the samples can be distinguished by mass spectrometry and determining from the mass spectrum the quantity of the target analyte in each sample. | 05-12-2011 |
20130123133 | SCREENING METHODS - The present invention provides materials and methods relating to screening for compounds useful in the treatment of Alzheimer's disease and related conditions. In particular, screening methods using tyrosine kinases are provided, as are methods relating to the role of tyrosine kinases as therapeutic targets. | 05-16-2013 |
20150051097 | Methods for Screening Inhibitors of Tau Phosphorylation By Casein Kinase I - Methods of screening for candidate compounds capable of inhibiting activity of fyn in phosphorylating tau protein at Y394 or binding to fyn to inhibit interaction with tau protein at Y394, including determining whether, and optionally the extent, the candidate compounds have these capabilities under conditions where fyn has these capabilities in the absence of the candidate compound. Methods of screening for substances capable of promoting dephosphorylation of tau protein by a phosphatase at a site of tau protein including contacting a candidate substance, the tau protein and a phosphatase capable of dephosphorylating the tau protein under conditions where the phosphatase is capable of dephosphorylating the site in absence of the candidate substance, where the kinase is fyn; determining whether, and optionally the extent, the candidate substance promotes dephosphorylation of the tau protein at the site; and selecting the candidate substance which promotes dephosphorylation of the tau protein the sites. | 02-19-2015 |
Helen Byers, Cobham Surrey GB
Patent application number | Description | Published |
---|---|---|
20110165146 | METHODS OF DIAGNOSING ALZHEIMER'S DISEASE - Methods and compositions relating to Alzheimer's disease are provided. Specifically, proteins that are differentially expressed in the Alzheimer's disease state relative to their expression in the normal state are provided. Proteins associated with Alzheimer's disease are identified and described. Methods of diagnosis of Alzheimer's disease using the differentially expressed proteins are also provided, as are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimer's disease. | 07-07-2011 |
Helen Louise Byers, Cobham GB
Patent application number | Description | Published |
---|---|---|
20120071337 | METHODS - The invention provides a method for aiding the diagnosis or prognostic monitoring of Alzheimer's disease in a subject, said method comprising; providing a sample of blood obtained from said patient; assaying the amount of gelsolin present in said sample; comparing the amount of gelsolin present in said sample to a reference amount of gelsolin present in a sample from a healthy subject, wherein detection of a gelsolin level in the sample from said patient which is lower than the gelsolin level in the reference sample indicates an increased likelihood of Alzheimer's disease in said patient. Other markers are C1 protease inhibitor and ceruloplasmin. Both blood samples and tissue samples have been investigated. | 03-22-2012 |
Helen Louise Byers, London GB
Patent application number | Description | Published |
---|---|---|
20080213802 | Diagnosis of Neurodegenerative Diseases - The invention relates to a method of diagnosis of vCJD in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a sample of a control human subject, the protein being: beta-actin (SwissProt Ace. No. P60709), apolipoprotein A-IV precursor (SwissProt Acc. No. P06727); haptoglobin beta-chain consisting of residues 162-406 (SwissProt Acc. No. P00738); haemoglobin beta chain (SwissProt Ace. No. P02023); or alpha-1-antitrypsin (SwissProt Ace. No. P01009); or a decreased concentration of a protein in the diagnostic sample, compared with a sample of a control, normal human subject, the protein being plasma protease (C1) inhibitor precursor (SwissProt Acc. No. P05155); complement component 1, s sub-component (SwissProt Acc. No. P09871); butyrylcholinesterase precursor (SwissProt Acc. No. P06276); complement component C4B (SwissProt Acc. No. P01028); lumican (SwissProt Ace. No. P51884); alpha-fibrinogen precursor (SwissProt Ace. No. P02671); IGHG4 protein (Swiss Prot Ace. No. Q8TC63) or immunoglobulin lambda heavy chain. Other marker proteins are also disclosed. | 09-04-2008 |
John G. Byers, Batesville, IN US
Patent application number | Description | Published |
---|---|---|
20140041119 | PERSON SUPPORT APPARATUS POWER DRIVE SYSTEM - A person support apparatus comprises a lower frame, an upper frame, a drive structure, and a control system. The upper frame is movably supported above the lower frame. The drive structure is coupled to the upper frame and configured to selectively engage a surface to, when activated, propel the person support apparatus along the surface. The control system is configured to determine an engagement status of the drive structure with the surface and trigger a response based on the engagement status. | 02-13-2014 |
John S. Byers, Dundee GB
Patent application number | Description | Published |
---|---|---|
20090199164 | Interoperability method and software - Interoperability software modules comprise an architected .NET layer, an architected interpreter, an automatic interpreter and a library of COM objects. The architected interpreter where they are mapped to intermediate .NET interfaces compatible with the automatic interpreter by means of a Runtime Callable Wrapper (RCW). The architected interpreter also comprises an architected COM Callable Wrapper (CCW) that maps the intermediate COM interfaces into architected interfaces. | 08-06-2009 |
John Scott Byers, Perthshire GB
Patent application number | Description | Published |
---|---|---|
20150120542 | SYSTEM AND METHOD FOR OVERRIDING RULE DRIVEN AUTOMATED DECISIONS - A system and method for overriding rule-driven automated decisions that result from the use of an automated consumer device associated with rule-driven automated systems. In an aspect, the automated rules-driven override system comprises an automated consumer device, an interactive server, core decision systems, and an override device. In an aspect, the automated consumer device, the interactive server and the override device are configured to work in concert with one another to override certain decisions performed by the core decision systems. | 04-30-2015 |
Jonathan Wood Byers, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20160136573 | DESULFURIZATION OF FLUE GAS FROM AN AMINE PROCESS - A method for disposing of excess sulfur dioxide in a flue gas from thermal oxidation of an acid gas stream including hydrogen sulfide recovered from a rich amine solution of an amine plant servicing at least one well head, includes cooling the flue gas to about 300 to about 650 degrees Fahrenheit, injecting a dry sorbent into the flue gas after the step of cooling the flue gas, reacting the dry sorbent after the step of injection, with the sulfur dioxide of the flue gas for sufficient time for formation of reaction byproduct and treated gas, and separating the reaction byproduct from the treated gas. Examples of the dry sorbent include calcium hydroxide, sodium bicarbonate, and trona, as well as magnesium hydroxide and sodium carbonate, and combinations. | 05-19-2016 |
Lauren A. Byers, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20130230511 | BIOMARKERS FOR RESPONSE TO TYROSINE KINASE PATHWAY INHIBITORS IN CANCER - Copy number gains detected in tumors and associated with drug sensitivity and resistance in vivo and in vitro can be used as biomarkers to select, predict and monitor drug treatment outcomes in cancer patients treated with tyrosine kinase inhibitors. Methods to identify patients with NSCLC or other malignancies who are more likely to benefit from tyrosine kinase inhibitors such as VEGF or VEGFR inhibitors when used either as monotherapy or in combination with other therapies such as chemotherapy or EGFR inhibitors, and who are in the advanced stages of disease and/or who have undergone adjuvant therapy are also provided herein. | 09-05-2013 |
Lauren Averett Byers, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20140155397 | EMT SIGNATURES AND PREDICTIVE MARKERS AND METHOD OF USING THE SAME - EMT signatures and markers useful for characterizing the status of epithelial cancers and for predicting drug responses in patients having non-small cell lung cancer are provided together with methods of using the same. | 06-05-2014 |
Liam Byers, Lunenburg, MA US
Patent application number | Description | Published |
---|---|---|
20140175800 | Non-Rotating Wind Energy Generator - In an embodiment of the invention, a non-rotating wind energy generator uses the fluid flow principles of vortex shedding and transverse galloping to generate oscillatory, linear motion of a beam, and linear alternators, optionally located near both ends of the beam, generate electrical power when the beam is in motion. | 06-26-2014 |
20160076521 | NON-ROTATING WIND ENERGY GENERATOR - In an embodiment of the invention, a non-rotating wind energy generator uses the fluid flow principles of vortex shedding and transverse galloping to generate oscillatory motion of a beam, and alternators, optionally located near both ends of the beam, generate electrical power when the beam is in motion. | 03-17-2016 |
Mathew Simon Byers, Christchurch NZ
Patent application number | Description | Published |
---|---|---|
20130296240 | PNEUMONIA BIOMARKERS - Ghrelin signal peptide fragment assays and kits useful in the diagnosis, prognosis, risk stratification, assessing, staging, monitoring, categorizing and determination of further diagnoses and treatment regimens in subjects with various disorders, diseases and conditions including, pneumonia, heart failure, or pneumonia and heart failure or suspected pneumonia, heart failure, or pneumonia and heart failure, and methods for monitoring treatment. | 11-07-2013 |
Philip M. Byers, Tallahassee, FL US
Patent application number | Description | Published |
---|---|---|
20130109855 | Modular Synthesis of Graphene Nanoribbons And Graphene Substructures From Oligo-Alkynes | 05-02-2013 |
20150073145 | MODULAR SYNTHESIS OF GRAPHENE NANORIBBONS AND GRAPHENE SUBSTRUCTURES FROM OLIGO-ALKYNES - A method for the synthesis of carbon-based structures, particularly graphene substructures and ribbons, from oligo- and poly-alkyne starting materials. | 03-12-2015 |
Richard John Byers, Manchester GB
Patent application number | Description | Published |
---|---|---|
20150098641 | Biomarker Method - Provided herein is a method for quantifying the spatial distribution of cells or sub-cellular structures comprising (a) receiving image data comprising a plurality of biomarkers, N, wherein the data represents a spatial map of the biomarkers; (b) processing the data to obtain a set of coordinates, wherein each coordinate denotes the location of a cell or sub-cellular structure represented by a biomarker or combination of biomarkers; and (c) processing the set of coordinates into a two-dimensional symmetric (2 | 04-09-2015 |
Richard M. Byers, Waterloo CA
Patent application number | Description | Published |
---|---|---|
20130066622 | SIMULATION OF STATIC MEMBERS AND PARAMETERIZED CONSTRUCTORS ON AN INTERFACE-BASED API - Embodiments are directed to providing a simulation of a type-level construct on an interface instance and to maintaining a token-based event handling system. In one scenario, a computer system instantiates an interface instance that includes an instance object and multiple instance members. The computer system also instantiates a separate typed object which is configured to maintain one or more simulated type-level parameterized constructors. The computer system then associates the instantiated interface instance with the separate typed object. The typed object routes method invocations from the interface instance to various simulated type-level parameterized constructors and static members of the type. | 03-14-2013 |
20130067053 | EFFICIENTLY PROVIDING MULTIPLE METADATA REPRESENTATIONS OF THE SAME TYPE - Embodiments are directed to dynamically adapting metadata for use with a native data encoding and to efficiently modifying object model type references. In one scenario, a computer system instantiates a metadata reader over an object model description to access various portions of metadata in the object model description. The metadata reader is configured to read native metadata, where native metadata is metadata represented in an encoding that is expected by the metadata reader. The metadata reader determines that the accessed metadata is encoded in a non-native encoding and then determines which metadata modifications are to be performed to transform the non-native encoding into a native encoding. The computer system then dynamically adapts the metadata of the object model from a non-native encoding to a native encoding according to the determined modifications. As such, the object model is readable by a native runtime. | 03-14-2013 |
20140379740 | EFFICIENTLY PROVIDING MULTIPLE METADATA REPRESENTATIONS OF THE SAME TYPE - Embodiments are directed to dynamically adapting metadata for use with a native data encoding and to efficiently modifying object model type references. In one scenario, a computer system instantiates a metadata reader over an object model description to access various portions of metadata in the object model description. The metadata reader is configured to read native metadata, where native metadata is metadata represented in an encoding that is expected by the metadata reader. The metadata reader determines that the accessed metadata is encoded in a non-native encoding and then determines which metadata modifications are to be performed to transform the non-native encoding into a native encoding. The computer system then dynamically adapts the metadata of the object model from a non-native encoding to a native encoding according to the determined modifications. As such, the object model is readable by a native runtime. | 12-25-2014 |
Robert Byers, Carlisle GB
Patent application number | Description | Published |
---|---|---|
20150097363 | PERSONAL MOBILITY VEHICLE RESTRAINT - A safety restraint adapted for securing a personal mobility vehicle in a transport vehicle, against movement in a direction opposite to the direction of normal motion of the transport vehicle, the safety restraint comprising: a retractor comprising a spool on which an elongate piece of material is wound; the elongate material being configured to be attached at one end to the personal mobility vehicle; a slider bar adapted to be fixed to the transport vehicle; and wherein the retractor is mounted on the slider bar, in a manner which allows the retractor to slide in the direction of normal motion of the transport vehicle, and prevents the retractor moving in the opposite direction on the slider bar. | 04-09-2015 |
Ronnie Ken Byers, Pullman, WA US
Patent application number | Description | Published |
---|---|---|
20150063408 | GASEOUS CONCENTRATION MEASUREMENT APPARATUS - An apparatus is configured to measure various properties of sample in a sample chamber such as, for example, water activity. The apparatus includes a tunable diode laser that emits laser radiation into the sealed chamber without passing through the air outside the sample chamber or a wall of the sample chamber. The laser radiation only passes through the gaseous mixture in the sample chamber. A temperature sensor such as an infrared thermometer is positioned to measure the temperature of a sample in the sample chamber. The apparatus may be configured to include a plurality of sample containers each of which includes a sealed sample chamber. The sample containers may be automatically fed through the apparatus and analyzed with the tunable diode laser without any operator input or interaction. | 03-05-2015 |
Russ Byers, Manotick CA
Patent application number | Description | Published |
---|---|---|
20120146689 | DIFFERENTIAL SIGNAL TERMINATION CIRCUIT - A multi-mode differential termination circuit has a pair of differential input terminals for receiving external differential signals, a pair of series-connected load elements coupled between said differential input terminals, and an analog interface terminal coupled a common junction point of said load elements. A bias circuit is coupled to the common junction point of the load elements for selectively applying a bias voltage thereto in response to a digital control signal. A control input receives the digital control signal to activate the bias circuit. | 06-14-2012 |
Sarah E. Byers, Marietta, GA US
Patent application number | Description | Published |
---|---|---|
20140365253 | System for Calculating, Analyzing and Tracking Regulatory Recovery in a Relational Database relating to Regulatory Management - A system for calculating, analyzing and tracking regulatory recovery relating to regulatory management has been developed. The system includes, a mapping interface for mapping the source data from multiple source databases, analysis keys that are applied and act as data tags to the mapped source data and a storage database for storing the mapped source data. A jurisdictional template is used for filtering mapped source data in order to model the data for a specific jurisdiction. Next, a case ledger layer that generates rate cases based on filtered mapped source data. A regulatory monitoring tool is then used to monitor regulatory recovery performance. Finally, a revenue requirements manager that analyzes both historical and forecast rate cases generates a user report. | 12-11-2014 |
Simon D. Byers, Summitt, NJ US
Patent application number | Description | Published |
---|---|---|
20160057202 | Sharing Asserted Media - Concepts and technologies are disclosed herein for sharing asserted media. An assertion application can be executed by a device to generate asserted media. The assertion application can receive a request or other input for specifying information to be included in the asserted media. The assertion application also can be executed to obtain media captured with a media capture device and to obtain the information to be included in the asserted media. The assertion application also can associate the information with the media content to generate the asserted media and share the asserted media with one or more recipients. An assertion service remote from the user device can be configured to generate the asserted media and/or to share the asserted media with the recipients. | 02-25-2016 |
Stephen W. Byers, Takoma Park, MD US
Patent application number | Description | Published |
---|---|---|
20130331328 | SMALL MOLECULE INHIBITORS OF AGBL2 - Small molecule inhibitors of AGBL2 are provided, as well as methods of using the inhibitors to treat or prevent cancer and neurologic disorders. | 12-12-2013 |
Terry Byers, Flushing, MI US
Patent application number | Description | Published |
---|---|---|
20150090273 | WRAPPABLE STERILE RADIATION SHIELD DRAPE, COMBINATION OF A RADIATION SHIELD AND STERILE DRAPE THEREFOR AND METHOD OF PROVIDING A STERILE DRAPE ABOUT A RADIATION SHIELD - A wrappable sterile radiation shield drape, a wrappable sterile radiation shield drape in combination with a radiation shield, and a method of providing a sterile surface about a suspended radiation shield is provided. The drape includes a flexible wall having a sterilized outer surface. The wall has opposite side edges extending between upper and lower ends and an upper fastener adjacent its upper end. The upper fastener is configured to releasably fix the upper end of the wall relative to the radiation shield. The wall further includes an edge fastener adjacent at least one of its side edges. The edge fastener is configured to releasably maintain the wall in a wrapped configuration about the radiation shield. The wall further includes at least one flap attached adjacent the upper end, wherein the flap includes a pocket configured to receive a shoulder extension portion of the radiation shield. | 04-02-2015 |
William A. Byers, Murrysville, PA US
Patent application number | Description | Published |
---|---|---|
20160035442 | CHEMICAL PROCESS FOR PRIMARY SYSTEM MATERIAL PASSIVATION DURING HOT FUNCTIONAL TESTING OF NUCLEAR POWER PLANTS - The present invention relates to a pre-core hot functional testing (HFT) preconditioning process, which includes the introduction of chemical additives, e.g., zinc, into coolant water that circulates through the primary system of a new nuclear power plant, at various temperatures. The chemical additives contact the primary system surfaces, which results in the formation of a protective zinc-containing oxide film on the fresh surfaces to control corrosion release and deposition during subsequent normal operation of the nuclear power plant. The method includes a series of three chemistry phases to optimize the passivation process: 1) an alkaline-reducing phase, 2) an acid-reducing phase and 3) an acid-oxidizing phase. | 02-04-2016 |